Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM

by NASDAQ Market News October 1, 2019

NASDAQ Market News
Click here to email author

American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa

Single-Inhaler Extrafine Triple Therapy of Inhaled Corticosteroid, Long-Acting B2-Agonist and Long-Acting Muscarinic Antagonist Therapy Improves Lung Function and Reduces Asthma Exacerbations(1)

Ads